0000899243-23-001632.txt : 20230111 0000899243-23-001632.hdr.sgml : 20230111 20230111195136 ACCESSION NUMBER: 0000899243-23-001632 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230110 FILED AS OF DATE: 20230111 DATE AS OF CHANGE: 20230111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lamy Patrick CENTRAL INDEX KEY: 0001961273 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38944 FILM NUMBER: 23524649 MAIL ADDRESS: STREET 1: AKERO THERAPEUTICS, INC. STREET 2: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akero Therapeutics, Inc. CENTRAL INDEX KEY: 0001744659 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-487-6488 MAIL ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-10 0 0001744659 Akero Therapeutics, Inc. AKRO 0001961273 Lamy Patrick C/O AKERO THERAPEUTICS, INC., 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 See Remarks Stock Option (Right to Buy) 44.37 2023-01-10 4 A 0 100000 0.00 D 2033-01-09 Common Stock 100000 100000 D This option shall vest and become exercisable in forty-eight (48) equal monthly installments, commencing on January 10, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. Senior Vice President, Commercial Strategy /s/ Jonathan Young, attorney-in-fact 2023-01-11